All In Biotech

Drug Trial Radar · NCT06663176

Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa)

Phase 1/2a Trial to Evaluate the Safety, Tolerability and Efficacy of Nebulised RESP30X Nitric Oxide Formulations in Non-Cystic Fibrosis Bronchiectasis (NCFB) Patients With Pseudomonas Aeruginosa (Pa) or Other Potentially Pathogenic Micro-organisms (PPMs)

Last checked: Nov 19, 2026Latest source record: Mar 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Oct 16, 2024

Primary completion

Feb 5, 2028

Study completion May 5, 2028

Sponsor

Lead sponsor
Thirty Respiratory LimitedIndustry
Sponsor type
Industry
First posted
Oct 29, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 1/2a, Multi-Centre, Randomised, Open-label study to assess the safety, tolerability, PK, and efficacy of RESP30X in Adult NCFB participants with confirmed high-titre respiratory PPMs.

Conditions

  • Non-Cystic Fibrosis Bronchiectasis

Interventions

  • RESP302Drug

    Nitric Oxide agent

  • RESP303Drug

    Nitric Oxide agent

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence, intensity, causality, and seriousness of treatment-emergent adverse events (TEAEs).Time frame: 58 days
  2. Changes in clinical laboratory values (haematology, clinical chemistry) at each time point.Time frame: 58 days
  3. Changes in vital signs (blood pressure, heart rate, temperature, respiratory rate) and SpO2 at each time point.Time frame: 58 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • ARENSIA Exploratory Medicine

    Kyiv, Ukraine

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.